By Nancy Lapid June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

Every day, thousands of people worldwide suffer a heart attack, often leading to lasting damage to the heart muscle. Recent research from the University of Oslo suggests that targeting inflammation in ...

You’ve tried one antidepressant. Then another. Maybe a third, with a different mechanism, a different dosage, a different promise. And while some people do find meaningful relief through that ...

A cohort study published in the Journal of the American Medical Association found that among patients with nonvalvular atrial ...

Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that looked at health data from over 130 million ...

Ozempic, Zepbound and other glucagonlike peptide 1 (GLP-1) drugs have shown sweeping health benefits—they can control blood sugar, manage body weight and improve heart health. And last year GLP-1 ...

The advice especially applies if you are also taking other medication ...

A new study reveals that flu drugs can reduce cognitive decline and biological aging by preserving protective glycan sugars.

An international research team, including scientists from the Institut de Neurociències at the Universitat Autònoma de Barcelona (UAB), has developed a new solution to reduce the immune response ...